(Stroke. 2005;36:1153.)
© 2005 American Heart Association, Inc.
Original Contributions |
From the Departments of Neurology (K.S.B., S.D.), Clinical Epidemiology (L.M.), and Radiology (B.T.), Royal Melbourne Hospital, University of Melbourne, Australia; the Department of Neurology, John Hunter Hospital, Newcastle, Australia (M.P., C.L.); the Department of Neurology, Auckland Hospital, New Zealand (P.A.B.); the Department of Neurology, Box Hill Hospital, Melbourne, Australia (C.B.); the Department of Neurology, Royal Adelaide Hospital, Adelaide, Australia (T.K.); the Department of Neurology, Flinders Medical Centre, Adelaide, Australia (D.S.); the Department of Neurology, Christchurch Hospital, New Zealand (J.F.); and the Department of Neurology, Austin Hospital, Melbourne, Australia (G.D.).
Correspondence to Kenneth S. Butcher, Royal Melbourne Hospital, Grattan St, Parkville, Victoria, Australia 3050. E-mail kenneth.butcher{at}mh.org.au
Background and Purpose The Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) tests the hypothesis that perfusion-weighted imaging (PWI)diffusion-weighted imaging (DWI) mismatch predicts the response to thrombolysis. There is no accepted standardized definition of PWI-DWI mismatch. We compared common mismatch definitions in the initial 40 EPITHET patients.
Methods Raw perfusion images were used to generate maps of time to peak (TTP), mean transit time (MTT), time to peak of the impulse response (Tmax) and first moment transit time (FMT). DWI, apparent diffusion coefficient (ADC), and PWI volumes were measured with planimetric and thresholding techniques. Correlations between mismatch volume (PWIvol-DWIvol) and DWI expansion (T2Day 90-vol-DWIAcute-vol) were also assessed.
Results Mean age was 68±11, time to MRI 4.5±0.7 hours, and median National Institutes of Health Stroke Scale (NIHSS) score 11 (range 4 to 23). Tmax and MTT hypoperfusion volumes were significantly lower than those calculated with TTP and FMT maps (P<0.001). Mismatch
20% was observed in 89% (Tmax) to 92% (TTP/FMT/MTT) of patients. Application of a +4s (relative to the contralateral hemisphere) PWI threshold reduced the frequency of positive mismatch volumes (TTP 73%/FMT 68%/Tmax 54%/MTT 43%). Mismatch was not significantly different when assessed with ADC maps. Mismatch volume, calculated with all parameters and thresholds, was not significantly correlated with DWI expansion. In contrast, reperfusion was correlated inversely with infarct growth (R=0.51; P=0.009).
Conclusions Deconvolution and application of PWI thresholds provide more conservative estimates of tissue at risk and decrease the frequency of mismatch accordingly. The precise definition may not be critical; however, because reperfusion alters tissue fate irrespective of mismatch.
Key Words: magnetic resonance imaging, diffusion-weighted magnetic resonance imaging, perfusion-weighted thrombolysis
This article has been cited by other articles:
![]() |
J. M. Provenzale and M. Wintermark Optimization of Perfusion Imaging for Acute Cerebral Ischemia: Review of Recent Clinical Trials and Recommendations for Future Studies Am. J. Roentgenol., October 1, 2008; 191(4): 1263 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Dani, M. T. McCormick, and K. W. Muir Brain Lesion Volume and Capacity for Consent in Stroke Trials: Potential Regulatory Barriers to the Use of Surrogate Markers Stroke, August 1, 2008; 39(8): 2336 - 2340. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Y Bang, J L Saver, B H Buck, J R Alger, S Starkman, B Ovbiagele, D Kim, R Jahan, G R Duckwiler, S R Yoon, et al. Impact of collateral flow on tissue fate in acute ischaemic stroke J. Neurol. Neurosurg. Psychiatry, June 1, 2008; 79(6): 625 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
F CHEN, Q LIU, H WANG, Y SUZUKI, N NAGAI, J YU, G MARCHAL, and Y NI Comparing two methods for assessment of perfusion-diffusion mismatch in a rodent model of ischaemic stroke: a pilot study Br. J. Radiol., March 1, 2008; 81(963): 192 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kane, T. Carpenter, F. Chappell, C. Rivers, P. Armitage, P. Sandercock, and J. Wardlaw Comparison of 10 Different Magnetic Resonance Perfusion Imaging Processing Methods in Acute Ischemic Stroke: Effect on Lesion Size, Proportion of Patients With Diffusion/Perfusion Mismatch, Clinical Scores, and Radiologic Outcomes Stroke, December 1, 2007; 38(12): 3158 - 3164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Luby and S. Warach Reliability of MR Perfusion-Weighted and Diffusion-Weighted Imaging Mismatch Measurement Methods AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1674 - 1678. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Kane, P Sandercock, and J Wardlaw Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 485 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Parsons, E. M. Pepper, G. A. Bateman, Y. Wang, and C. R. Levi Identification of the penumbra and infarct core on hyperacute noncontrast and perfusion CT Neurology, March 6, 2007; 68(10): 730 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Wu, S. Christensen, N. Hjort, R. M. Dijkhuizen, T. Kucinski, J. Fiehler, G. Thomalla, J. Rother, and L. Ostergaard Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI Brain, September 1, 2006; 129(9): 2384 - 2393. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Allport, T. Baird, K. Butcher, L. MacGregor, J. Prosser, P. Colman, and S. Davis Frequency and Temporal Profile of Poststroke Hyperglycemia Using Continuous Glucose Monitoring Diabetes Care, August 1, 2006; 29(8): 1839 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Arakawa, P. M. Wright, M. Koga, T. G. Phan, D. C. Reutens, I. Lim, M. R. Gunawan, H. Ma, N. Perera, J. Ly, et al. Ischemic Thresholds for Gray and White Matter: A Diffusion and Perfusion Magnetic Resonance Study Stroke, May 1, 2006; 37(5): 1211 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Furlan, D. Eyding, G. W. Albers, Y. Al-Rawi, K. R. Lees, H. A. Rowley, C. Sachara, M. Soehngen, S. Warach, W. Hacke, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset Stroke, May 1, 2006; 37(5): 1227 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Warach and J. Wardlaw Advances in Imaging 2005 Stroke, February 1, 2006; 37(2): 297 - 298. [Full Text] [PDF] |
||||
![]() |
L. E. Allport, M. W. Parsons, K. S. Butcher, L. MacGregor, P. M. Desmond, B. M. Tress, and S. M. Davis Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke Neurology, November 8, 2005; 65(9): 1382 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Prosser, K. Butcher, L. Allport, M. Parsons, L. MacGregor, P. Desmond, B. Tress, and S. Davis Clinical-Diffusion Mismatch Predicts the Putative Penumbra With High Specificity Stroke, August 1, 2005; 36(8): 1700 - 1704. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |